Grantham, Mayo, Van Otterloo & Co (GMO)
CL icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Colgate-Palmolive CL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.04M Buy
54,924
+10,672
+24% +$934K 0.01% 327
2026
Q1 		$3.77M Buy
44,252
+3,687
+9% +$329K 0.01% 359
2025
Q4 		$3.21M Sell
40,565
-40
-0.1% -$3.14K 0.01% 367
2025
Q3 		$3.25M Buy
40,605
+27,796
+217% +$2.37M 0.01% 333
2025
Q2 		$1.16M Sell
12,809
-6,820
-35% -$623K ﹤0.01% 455
2025
Q1 		$1.84M Buy
19,629
+6,952
+55% +$622K 0.01% 383
2024
Q4 		$1.15M Buy
12,677
+495
+4% +$47.2K ﹤0.01% 434
2024
Q3 		$1.26M Buy
12,182
+1,413
+13% +$144K ﹤0.01% 408
2024
Q2 		$1.05M Buy
+10,769
New +$993K ﹤0.01% 395
2023
Q4 		– Sell
-28,480
Closed -$2.03M – 508
2023
Q3 		$2.03M Sell
28,480
-38,663
-58% -$2.89M 0.01% 408
2023
Q2 		$5.17M Buy
+67,143
New +$5.2M 0.02% 325
2022
Q2 		– Sell
-167,275
Closed -$12.7M – 759
2022
Q1 		$12.7M Buy
167,275
+8,668
+5% +$687K 0.06% 226
2021
Q4 		$13.5M Sell
158,607
-41,464
-21% -$3.24M 0.07% 212
2021
Q3 		$15.1M Buy
200,071
+29,436
+17% +$2.34M 0.07% 201
2021
Q2 		$13.9M Buy
170,635
+98,615
+137% +$8.06M 0.07% 208
2021
Q1 		$5.68M Buy
72,020
+45,700
+174% +$3.58M 0.03% 291
2020
Q4 		$2.25M Sell
26,320
-45,998
-64% -$3.8M 0.01% 424
2020
Q3 		$5.58M Hold
72,318
– – 0.04% 223
2020
Q2 		$5.3M Sell
72,318
-6,200
-8% -$440K 0.04% 239
2020
Q1 		$5.21M Buy
78,518
+11,471
+17% +$809K 0.04% 236
2019
Q4 		$4.62M Sell
67,047
-48,935
-42% -$3.34M 0.03% 296
2019
Q3 		$8.53M Sell
115,982
-17,900
-13% -$1.3M 0.06% 212
2019
Q2 		$9.6M Buy
+133,882
New +$9.5M 0.07% 194
2018
Q4 		– Sell
-271,670
Closed -$18.2M – 541
2018
Q3 		$18.2M Sell
271,670
-330,238
-55% -$22M 0.12% 113
2018
Q2 		$39M Buy
601,908
+4,852
+0.8% +$317K 0.28% 57
2018
Q1 		$42.8M Buy
597,056
+580,159
+3,434% +$41.7M 0.26% 68
2017
Q4 		$1.27M Sell
16,897
-50,949
-75% -$3.72M 0.01% 351
2017
Q3 		$4.94M Buy
+67,846
New +$4.89M 0.03% 222
2017
Q2 		– Sell
-46,719
Closed -$3.42M – 587
2017
Q1 		$3.42M Sell
46,719
-984,224
-95% -$68.9M 0.02% 276
2016
Q4 		$67.5M Sell
1,030,943
-1,091,767
-51% -$74.9M 0.36% 74
2016
Q3 		$157M Sell
2,122,710
-637,932
-23% -$47.2M 0.74% 28
2016
Q2 		$202M Buy
2,760,642
+475,943
+21% +$33.9M 0.83% 27
2016
Q1 		$161M Sell
2,284,699
-378,572
-14% -$25.2M 0.6% 40
2015
Q4 		$177M Sell
2,663,271
-2,059,527
-44% -$137M 0.64% 41
2015
Q3 		$300M Sell
4,722,798
-1,370,906
-22% -$89.6M 1.04% 21
2015
Q2 		$399M Sell
6,093,704
-2,867,200
-32% -$195M 1.29% 20
2015
Q1 		$621M Buy
8,960,904
+283,910
+3% +$19.6M 1.85% 15
2014
Q4 		$600M Buy
8,676,994
+783,055
+10% +$52.9M 1.62% 16
2014
Q3 		$515M Sell
7,893,939
-64,620
-0.8% -$4.26M 1.36% 19
2014
Q2 		$543M Sell
7,958,559
-1,402,387
-15% -$94M 1.47% 18
2014
Q1 		$607M Sell
9,360,946
-943,880
-9% -$59.5M 1.58% 18
2013
Q4 		$672M Sell
10,304,826
-769,610
-7% -$49.3M 1.63% 19
2013
Q3 		$657M Sell
11,074,436
-1,609,440
-13% -$95.4M 1.73% 16
2013
Q2 		$727M Buy
+12,683,876
New +$753M 1.89% 17

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Colgate-Palmolive (CL) stake by 24% in Q2 2026, buying an estimated $934K and bringing the position to 54,924 shares worth $5.04M. The position accounts for 0.01% of the portfolio, ranked #327.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CL in Q2 2013 and has held it in 44 quarters since. The position peaked at $727M in Q2 2013. 2,015 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 54,924 shares of Colgate-Palmolive worth $5.04M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 10,672 Colgate-Palmolive shares in Q2 2026, an estimated $934K.
  • Colgate-Palmolive made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #327 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 44 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Colgate-Palmolive position peaked at $727M in Q2 2013.
  • 2,015 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.